On November 29, 2023, Theralase Technologies Inc. closed the transaction. The company amended the terms of the transaction and issued an aggregate of 5,318,183 units at a price of CAD 0.22 per unit for the gross proceeds of up to approximately CAD 1,170,000.26. In connection with the offering, the company paid a finder's fee of CAD 5,810 in cash and issued 18,864 non-transferrable finder units of the company. The offering is subject to receipt of final acceptance from the TSX Venture Exchange.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 28 placees including existing insider involvement of one insider for 461,282.